05.30.08
Posted in Uncategorized at 6:14 pm by American Cancer Society :: News and Features
More than 4,000 abstracts will be presented this weekend at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Permalink
Posted in Uncategorized at 5:00 pm by Cancer / Oncology News From Medical News Today
Clavis Pharma ASA (OSE: CLAVIS) will present results from the Phase I part of its Phase I/II study with ELACYT, within haematological cancers, at the American Society of Clinical Oncology (ASCO) Annual Meeting 2008, to be held in Chicago on 30 May to 3 June. The poster will be presented from 2:00PM to 6:00PM (CDT) on 1 June 2008 and includes updated results from all 77 patients treated in the study.
Permalink
Posted in Uncategorized at 1:00 pm by Cancer / Oncology News From Medical News Today
Sen. Chuck Grassley's (R-Iowa) request that the Government Accountability Office investigate whether FDA acted appropriately in granting "accelerated approval" to a cancer drug "will have a catastrophic effect on America's ability to develop new drugs," Mark Thornton, a former medical officer in FDA's
Permalink
Posted in Uncategorized at 9:00 am by Cancer / Oncology News From Medical News Today
Sen. Edward Kennedy (D-Mass.), who recently was diagnosed with brain cancer, previously had begun work on legislation that would revise the 1971 National Cancer Act, and supporters hope that the "fact that Kennedy has fallen victim to this disease will generate public support and lend new urgency to the need to update the bill," the AP/Chicago Tribune reports.
Permalink
Posted in Uncategorized at 9:00 am by Breast Cancer News From Medical News Today
The results of a phase III trial comparing Herceptin with chemo against chemo on its own showed that Herceptin helped women with aggressive metastatic HER2-positive breast cancer live nearly three months longer without their cancer progressing. The findings are being presented this weekend at the 44th annual meeting of the American Society for Clinical Oncology (ASCO) in Chicago.
Permalink
Posted in Uncategorized at 7:00 am by Cancer / Oncology News From Medical News Today
New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer."We were surprised to learn that there are still many patients who are not receiving the gold standard of chemotherapy and radiation after surgery - despite compelling clinical data available since 2001.
Permalink
Posted in Uncategorized at 7:00 am by Cancer / Oncology News From Medical News Today
New research from the Oregon Health & Science University Cancer Institute about mutations in melanoma may bring a wellspring of hope to many patients.Researchers have discovered that there are several different kinds of DNA abnormalities that can occur in a gene called the KIT gene. These abnormalities are associated with different kinds of acral and mucosal melanomas, which are less common, but highly malignant forms of skin cancer.
Permalink
Posted in Uncategorized at 5:00 am by Cancer / Oncology News From Medical News Today
Genmab A/S (OMX: GEN) reports that the last patient to be included in the planned interim analysis (N=132 patients) in the pivotal Phase III clinical trial of ofatumumab (HuMax-CD20(R)) in refractory chronic lymphocytic leukemia (CLL) has now received the last scheduled treatment.
Permalink
Posted in Uncategorized at 5:00 am by Cancer / Oncology News From Medical News Today
Physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center will present their latest research findings at the American Society of Clinical Oncology Annual Meeting in Chicago, May 30 to June 3.
Permalink
Posted in Uncategorized at 5:00 am by Cancer / Oncology News From Medical News Today
Condensing the sum of oncology know-how presented at major worldwide congresses prior to ECLU, the Lugano Conference presents a great opportunity to benefit from a comprehensive review of the latest cutting-edge information in oncology presented by renowned professionals in the field.The conference includes extensive opportunities for continuing medical education, professional development and clinical experience exchange.
Permalink
« Previous entries
